03:11 AM EDT, 09/30/2024 (MT Newswires) -- David Alan Campbell, Director, President and Chief Executive Officer, on September 27, 2024, sold 25,000 shares in Janux Therapeutics ( JANX ) for $1,157,641. Following the Form 4 filing with the SEC, Campbell has control over a total of 307,054 shares of the company, with 307,054 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1817713/000141588924024074/xslF345X05/form4-09272024_110948.xml